PGENPrecigen Inc
$3.93
$0.26
(6.31%)
Closed $3.86
$0.07
(1.81%)
After Hours
Reported EarningsMay 13
Mkt Cap$1.47B
Vol9.63M
Fundamentals
Mkt Cap
$1.47B
Volume
-
52W High
$5.47
52W Low
$1.28
PE Ratio
-3.33
Avg. Volume
3.92M
EPS (Annual)
-$1.37
Rev/Employee
$60,525.00
Earnings
May 13
54
Neutral Sentiment
How do you feel about PGEN?
Precigen, Inc. (PGEN) is a Great Momentum Stock: Should You Buy?
Does Precigen, Inc. (PGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete...
PR Newswire
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States PR Newswire GERMANTOWN, Md., May 27, 2026 FDA grants orphan drug exclusivity for...
PR Newswire
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire GERMANTOWN, Md., May 26, 2026...
PR Newswire
Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of +20.00% and +9.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Precigen Reports First Quarter 2026 Financial Results and Business Updates
Precigen Reports First Quarter 2026 Financial Results and Business Updates Precigen Reports First Quarter 2026 Financial Results and Business Updates PR Newswire GERMANTOWN, Md., May 13, 2026...
PR Newswire
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 PR...
PR Newswire
Precigen (PGEN) to Release Earnings on Wednesday
Precigen (NASDAQ:PGEN) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at...
MarketBeat
Precigen (NASDAQ:PGEN) Stock Crosses Below 200 Day Moving Average - Here's Why
Precigen (NASDAQ:PGEN) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell...
MarketBeat
<
1
2
...
>
Advertisement|Remove ads.
Latest PGEN News
ViewPrecigen, Inc. (PGEN) is a Great Momentum Stock: Should You Buy?
Zacks
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
PR Newswire
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
PR Newswire
Advertisement|Remove ads.